InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+6.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Dahl Andrew M., VP Senior. Insider active across 1 company, notably Edwards Lifesciences Corp. In total, 10 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €42k. Activity tracked since 13 September 2024. The latest transaction was disclosed on 29 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
567.527 shares@ US$86.080.0001% mcap37.3% of flowCommon StockSEC:0001225208-26-005647:0
3,985 shares0Common StockSEC:0001225208-26-005044:0
3,985 shares0Common StockSEC:0001225208-26-005044
176 shares@ US$79.780.0000% mcap20.4% of flowCommon StockSEC:0001225208-26-002408:0
176 shares@ US$79.7820.4% of flowCommon StockSEC:0001225208-26-002408
262 shares@ US$77.570.0000% mcap29.6% of flowCommon StockSEC:0001225208-25-007992:0
262 shares@ US$77.5729.6% of flowCommon StockSEC:0001225208-25-007992
3,335 shares0Common StockSEC:0001225208-25-004946:0
176 shares@ US$73.3010.9% of flowCommon StockSEC:0001225208-25-002308:0
2,920 shares0Common StockSEC:0001225208-24-008721:0
10 of 10 declarations
About Dahl Andrew M.
Andrew M. Dahl serves as Senior Vice President and Corporate Controller at Edwards Lifesciences Corp. He is responsible for overseeing financial functions and ensuring compliance with accounting standards. His role is crucial for ensuring transparency and financial accountability within the company.
